Endocrinology, Vol 124, 1507-1514, Copyright © 1989 by Endocrine Society

ARTICLES

Mammotroph autoregulation: the differential roles of the 24K isoforms of prolactin

TW Ho, JR Greenan and AM Walker
Division of Biomedical Sciences, University of California, Riverside 92521-0121.

In this study we have attempted to determine which of the secreted 24K isoforms was responsible for autocrine regulation of PRL secretion by comparing the isoforms synthesized and secreted by normal cells, which do autoregulate, with those synthesized and secreted by GH3 cells, which do not normally autoregulate. Comparable numbers of cells were washed free of serum and then extracted into Tris-buffered saline by sonication and detergent treatment. Proteins present in these cell extracts and in samples of culture medium were then precipitated with cold acetone (-20 C; 48 h) and subsequently dissolved in urea-lysis buffer for 2-dimensional (2-D) electrophoresis. The 2-D patterns for normal cells showed four 24K PRL isoforms inside the cells and three 24K PRL isoforms (designated 2, 3, and 3') secreted into the medium. The 2-D patterns for GH3 cells showed very little intracellular storage of PRL, but what was present was identified as 24K PRL isoform 2. The GH3 cells secreted large amounts of only 24K PRL isoform 2. Preparations of PRL containing only isoforms 1,2, and 3 (at a total radioimmunoassayable concentration of 5 micrograms/ml PRL) were capable of inducing autoregulation in GH3 cells, as evidence by decreased secretion of prelabeled intracellular PRL. Initiation of autoregulation in GH3 cells caused granulation and the intracellular production of isoform 3. Since a) a preparation containing isoforms 1, 2, and 3 was found to induce autoregulation in GH3 cells, b) isoform 1 is not a secreted form, and c) isoform 2 does not cause autoregulation (at least in GH3 cells), it is deduced that isoform 3 is an autocrine form of PRL. Since initiation of autoregulation in GH3 cells caused those cells to produce isoform 3, it is further deduced that the autoregulatory defect in GH3 cells lies in the actual lack of production of isoform 3 and not in an inherent inability of these cells to produce isoform 3.

This article has been cited by other articles:

				B C Nephew, J Amico, H M Cai, A M Walker, and R S Bridges Intracerebroventricular administration of the prolactin (PRL) receptor antagonist, S179D PRL, disrupts parturition in rats Reproduction, July 1, 2007; 134(1): 155 - 160. [Abstract] [Full Text] [PDF]

				M. E. Freeman, B. Kanyicska, A. Lerant, and G. Nagy Prolactin: Structure, Function, and Regulation of Secretion Physiol Rev, October 1, 2000; 80(4): 1523 - 1631. [Abstract] [Full Text] [PDF]

				D. Coss, C. B. Kuo, L. Yang, P. Ingleton, R. Luben, and A. M. Walker Dissociation of Janus Kinase 2 and Signal Transducer and Activator of Transcription 5 Activation after Treatment of Nb2 Cells with a Molecular Mimic of Phosphorylated Prolactin Endocrinology, November 1, 1999; 140(11): 5087 - 5094. [Abstract] [Full Text]

				T.-J. Chen, C. B. Kuo, K. F. Tsai, J.-W. Liu, D.-Y. Chen, and A. M. Walker Development of Recombinant Human Prolactin Receptor Antagonists by Molecular Mimicry of the Phosphorylated Hormone Endocrinology, February 1, 1998; 139(2): 609 - 616. [Abstract] [Full Text] [PDF]

				S.-K. Tan, F.-F. Wang, H.-F. Pu, and T.-C. Liu Differential Effect of Age on Transforming Growth Factor-{beta}1 Inhibition of Prolactin Gene Expression Versus Secretion in Rat Anterior Pituitary Cells Endocrinology, March 1, 1997; 138(3): 878 - 885. [Abstract] [Full Text] [PDF]

				Y.-F. Wang, J.-W. Liu, M. Mamidi, and A. M. Walker Identification of the Major Site of Rat Prolactin Phosphorylation as Serine 177 J. Biol. Chem., February 2, 1996; 271(5): 2462 - 2469. [Abstract] [Full Text] [PDF]

				P. M. Maciejewski, F. C. Peterson, P. J. Anderson, and C. L. Brooks Mutation of Serine 90 to Glutamic Acid Mimics Phosphorylation of Bovine Prolactin J. Biol. Chem., November 17, 1995; 270(46): 27661 - 27665. [Abstract] [Full Text] [PDF]